NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lief Therapeutics

Lief Therapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://lief.ai/

Last Round

Grant

Mar 2, 2026

Total Funding Raised

$4.12M

Company Overview

Lief Therapeutics is a digital health company that develops wearable biosensing patches and mobile applications to provide real-time heart rate variability (HRV) biofeedback for mental health management.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, Health IoT, Telemedicine, D2C Brands

Business Model

B2C

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

heart rate variabilityHRVbiofeedbackwearable medical devicestress managementdigital healthremote patient monitoringRPMmental health techECG monitoringbehavioral healthbiofeedback wearablestress trackeranxiety relief devicehealth coachingFDA class II device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lief Therapeutics Comparables

Compare Lief Therapeutics with similar companies based on industry and business-model similarity.

Lief Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The TouchPoint Solution
78%
Apollo Neuro
78%
Hoolest Inc.
78%

Lief Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 2, 2026
AcceleratorJul 25, 2019
CrowdfundingJan 10, 2017
CrowdfundingNov 29, 2016
SeedAug 1, 2015

Key People

Founding team and executive leadership

Rohan Dixit

CEO and Founder

Founding Team

Lief Therapeutics Investors

Notable investors and investment history

Lief Therapeutics investors
InvestorRounds
StartXSeed
Nashville Entrepreneur CenterAccelerator
Ayuh VenturesEarly Funding, Seed
ARPA-HGrant
HAXCrowdfunding, Seed

Lief Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lief Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lief Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2015
Last FundingMar 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.